Figure 5.
Challenge results of the eliciting-dose from DBPCC with rMal d 1 before and after 24 months of BP-AIT. Neg (4×): In four patients the DBPCC with rMal d 1 was negative at T0 and T24.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.